The Sugar.IQ app, which is now available to users of Medtronic’s Guardian Connect continuous glucose monitoring system via Apple’s App Store, uses artificial intelligence and analytics from IBM Watson Health to analyze how certain foods, insulin dosages and daily routines influence glucose levels.
Medtronic and IBM Watson Health’s goal for the app is to provide patients with personalized guidance addressing how best to control their glucose levels.
Patients who used the Sugar.IQ app spent 36 more minutes per day in the healthy glucose range than they did prior to downloading the app, according to research presented at the 78th Scientific Sessions of the American Diabetes Association June 22.
More articles on artificial intelligence:
USC researchers use AI to evaluate surgeons’ performance
Why AMA refers to ‘augmented intelligence,’ not ‘artificial intelligence,’ in new policy
MIT’s new AI can track people through walls — Here’s what that means for healthcare
